Deep immune profiling reveals targetable mechanisms of immune evasion in immune checkpoint inhibitor-refractory glioblastoma.
Saved in:
| Title: | Deep immune profiling reveals targetable mechanisms of immune evasion in immune checkpoint inhibitor-refractory glioblastoma. |
|---|---|
| Authors: | Simonds EF; Department of Neurology, University of California San Francisco, San Francisco, California, USA., Lu ED; Department of Neurology, University of California San Francisco, San Francisco, California, USA., Badillo O; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., Karimi S; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., Liu EV; Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, San Francisco, California, USA., Tamaki W; Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, San Francisco, California, USA., Rancan C; Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, San Francisco, California, USA., Downey KM; Department of Neurology, University of California San Francisco, San Francisco, California, USA., Stultz J; Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, San Francisco, California, USA., Sinha M; Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, San Francisco, California, USA., McHenry LK; Department of Neurology, University of California San Francisco, San Francisco, California, USA., Nasholm NM; Department of Neurology, University of California San Francisco, San Francisco, California, USA., Chuntova P; Department of Neurological Surgery, University of California San Francisco, San Francisco, California, USA., Sundström A; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., Genoud V; Translational Research Centre in Oncohaematology, Department of Medicine, University of Geneva, Geneva, Switzerland., Shahani SA; Department of Pediatrics, City of Hope National Medical Center, Duarte, California, USA., Wang LD; Department of Pediatrics, City of Hope National Medical Center, Duarte, California, USA.; Department of Immuno-Oncology, City of Hope National Medical Center, Duarte, California, USA., Brown CE; Departments of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte CA, Duarte, California, USA., Walker PR; Translational Research Centre in Oncohaematology, Department of Medicine, University of Geneva, Geneva, Switzerland., Swartling FJ; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., Fong L; Division of Hematology/Oncology, Department of Medicine, University of California San Francisco, San Francisco, California, USA.; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA., Okada H; Department of Neurological Surgery, University of California San Francisco, San Francisco, California, USA hideho.okada@ucsf.edu waweiss@gmail.com mats.hellstrom@igp.uu.se.; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA., Weiss WA; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA hideho.okada@ucsf.edu waweiss@gmail.com mats.hellstrom@igp.uu.se.; Departments of Neurology, Neurological Surgery, and Pediatrics, University of California San Francisco, San Francisco, California, USA.; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, USA., Hellström M; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden hideho.okada@ucsf.edu waweiss@gmail.com mats.hellstrom@igp.uu.se. |
| Source: | Journal for immunotherapy of cancer [J Immunother Cancer] 2021 Jun; Vol. 9 (6). |
| Publication Type: | Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
